Redhill Biopharma Ltd (NASDAQ:RDHL)

Data as of 3:59pm ET
 -0.45 / -4.39%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

RedHill Biopharma Ltd. is an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of clinical-stage, proprietary formulations and combinations of existing drugs for the treatment of inflammatory and gastrointestinal diseases, including cancer and related conditions. The Company's current pipeline of proprietary products includes: (i) RHB-104 - an oral combination therapy for the treatment of Crohn's disease, with an ongoing Phase III study, (ii) RHB-105 - an oral combination therapy for Helicobacter pylori infection, with an ongoing Phase III study; (iii) RHB-106 - an encapsulated formulation for bowel preparation licensed to Salix Pharmaceuticals Ltd.; (iv) RHB-103 - an oral thin film formulation of rizatriptan for acute migraines with U.S. NDA under FDA review; (v) RHB-102 - a once-daily oral pill formulation of ondansetron for the prevention of nausea and vomiting and, (vi) RHB-101 - a once-daily oral formulation of carvedilol. RedHill Biopharma was founded on August 3, 2009 and is headquartered in Tel Aviv, Israel.

Contact Information

RedHill Biopharma Ltd.
21 Ha'arba'a Street
Tel Aviv -- 64739
P:(723) 541-3131
Investor Relations:



Other institutional10.33%
Mutual fund holders0.18%
Individual stakeholders--

Top Executives

Dror Ben-AsherChairman & Chief Executive Officer
Ori ShiloDirector, Deputy CEO-Finance & Operations
Ira N. KalfusMedical Director
Reza FathiSenior Vice President-Research & Development
Thomas A. LangVice President-Regulatory & Clinical Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.